Form D — Exin Therapeutics, Inc.
0002109179-26-000001 · filed 2026-02-10
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $2,162,300
- Total sold
- $2,162,300
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Exin Therapeutics, Inc.
- CIK
- 2109179
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 2261 MARKET STREET STE 22614
SAN FRANCISCO, CA 94114 - Phone
- (650) 942-3715
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Gabriel Ocana Santero · Executive OfficerSAN FRANCISCO, CA Find on LinkedIn ↗
-
Ivan Alex Priela Lazarte · Executive OfficerSAN FRANCISCO, CA Find on LinkedIn ↗
-
Marko Tvrdic · Executive OfficerSAN FRANCISCO, CA Find on LinkedIn ↗
View original on SEC EDGAR.